checkAd

     185  0 Kommentare Results of Second Court Hearing

    BRISBANE, Australia, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Allkem Limited (ASX and TSX: AKE, “Allkem”) refers to the proposed merger of equals between Allkem and Livent Corporation (“Livent”), (“Transaction”).

    Allkem is pleased to announce that the Federal Court of Australia (“Court”) has today made orders approving the proposed scheme of arrangement pursuant to which Arcadium Lithium plc (“Arcadium Lithium”) will acquire 100% of the shares in Allkem (“Scheme”) in connection with the Transaction.

    Lodgement of Court Orders and Suspension of Trading

    Allkem expects to lodge an office copy of the Court’s orders with the Australian Securities and Investments Commission tomorrow, 21 December 2023, at which time the Scheme will become legally effective.

    If this occurs, Allkem expects that Allkem shares will be suspended from trading on ASX at the close of trading on 21 December 2023 (AEDT) and on TSX at 4:00 pm (Toronto time) on 21 December 2023. 

    Quotation and trading of Scheme Consideration

    Arcadium Lithium CDIs are expected to commence trading on ASX on a deferred settlement basis on 22 December 2023, and on a normal (T+2) settlement basis on 5 January 2024.1

    Arcadium Lithium shares are expected to commence trading on the New York Stock Exchange on 4 January 2023.

    Scheme Timetable

    The key remaining dates expected for the Transaction are set out below.

    Event   Date / time
    Election Date

    The latest time and date by which Election Forms (or Election Withdrawal Forms, if applicable) must be received by the Allkem Share Registry from:
    • Eligible Principal Register Shareholders who wish to receive Arcadium Lithium Shares, rather than Arcadium Lithium CDIs, as Scheme Consideration; and
    • Eligible Canadian Register Shareholders who wish to receive Arcadium Lithium CDIs, rather than Arcadium Lithium Shares, as Scheme Consideration.
      Principal Register Shareholders: 5:00 pm (AEDT) on 20 December 2023

    Canadian Register Shareholders: 5:00 pm (Toronto time) / 10:00 pm (UTC) on 20 December 2023
    Arcadium Lithium admitted to the official list of ASX   21 December 2023
    Effective Date   21 December 2023
    Suspension of Allkem Shares from trading on ASX   Close of trading on 21 December 2023 (AEDT)
    Suspension of Allkem Shares from trading on TSX   4:00 pm (Toronto time) / 9:00 pm (UTC) on 21 December 2023
    Arcadium Lithium CDIs to commence trading on ASX on a deferred settlement basis   22 December 2023
    Record Date for determining entitlements to receive Scheme Consideration   7:00 pm (AEDT) on 27 December 2023
    Scheme Implementation Date   4 January 2024
    US Merger Effective Time   4 January 2024 (New York time)
    Last day of deferred settlement trading for Arcadium Lithium CDIs   4 January 2024
    Arcadium Lithium Shares anticipated to commence trading on NYSE   9:30 am (New York time) on 4 January 2024
    Despatch of holding statements for Arcadium Lithium CDIs   5 January 2024
    Arcadium Lithium CDIs to commence trading on ASX on a normal settlement basis   10:00 am (AEDT) on 5 January 2024
    Expected date for Allkem to be delisted from ASX   Close of trading on 5 January 2023 (AEDT)
    Expected date for Allkem to be delisted from TSX   Close of trading on 5 January 2024 (Toronto time)
    First settlement of deferred settlement and normal settlement trading of Arcadium Lithium CDIs   9 January 2024

    Seite 1 von 2


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Results of Second Court Hearing BRISBANE, Australia, Dec. 21, 2023 (GLOBE NEWSWIRE) - Allkem Limited (ASX and TSX: AKE, “Allkem”) refers to the proposed merger of equals between Allkem and Livent Corporation (“Livent”), (“Transaction”). Allkem is pleased to …